VENOUS THROMBOEMBOLISM IN NORTHEAST MELBOURNE, AUSTRALIA: EVALUATION OF EPIDEMIOLOGY, RISK FACTORS AND TREATMENT STRATEGIES IN THE WARFARIN ERA

EHA Library, Hui Yin Lim, 100925

GADOLIN: PRIMARY RESULTS FROM A PHASE III STUDY OF OBINUTUZUMAB PLUS BENDAMUSTINE COMPARED WITH BENDAMUSTINE ALONE IN PATIENTS WITH RITUXIMAB-REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA

EHA Library, Laurie Sehn, 101340

PRELIMINARY PHASE II RESULTS OF ARA-C AND IDARUBICIN IN COMBINATION WITH SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) COMPOUND SELINEXOR (KPT-330) IN PATIENTS WITH RELAPSED OR REFRACTORY AML

EHA Library, Anne Kranich, 101346

RESULTS OF A PHASE 3 RANDOMIZED CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF IDELALISIB (IDELA) IN COMBINATION WITH OFATUMUMAB (OFA) FOR PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Timothy Dichiara, 101336

REGULATORY NETWORK GATA1-MEDIATED ON SEC23B GENE IN ERYTHROID CELLS

EHA Library, Roberta Russo, 103152

IN VITRO-GENERATED MYELOID-DERIVED SUPPRESSOR CELLS (MDSC) PREVENT MURINE GRAFT-VERSUS-HOST DISEASE (GVHD) BY INDUCING TYPE 2 T CELLS WITHOUT DISABLING ANTI-TUMOR CYTOTOXICITY

EHA Library, Gudrun Strauss, 103059

A LONGITUDINAL PROSPECTIVE STUDY EVALUATING THE EFFECTS OF ELTROMBOPAG (EPAG) TREATMENT ON BONE MARROW (BM) IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA: FINAL ANALYSIS

EHA Library, Uwe Platzbecker, 103062

BCR-ABL LEVELS AT LANDMARK TIMEPOINTS BETWEEN 1-3 YEARS OF IMATINIB ARE PREDICTIVE OF TIME TO A DEEP MOLECULAR RESPONSE AND CAN GUIDE THERAPY SWITCH DECISIONS WHERE TKI DISCONTINUATION IS THE GOAL

EHA Library, Susan Branford, 103075

A PHASE 2, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN PATIENTS (PTS) WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) AND ANEMIA REQUIRING TRANSFUSION

EHA Library, Rami S. Komrokji, 103078

GENOMIC AND DRUG RESPONSE PROFILING OF FATAL TCF3-HLF-POSITIVE PEDIATRIC ACUTE LYMPHOBLASTICLEUKEMIA IDENTIFIES RECURRENT MUTATION PATTERNS AND NOVEL THERAPEUTIC OPTIONS

EHA Library, Jean-Pierre Bourquin, 103182

DASATINIB (DAS) IN COMBINATION WITH CHEMOTHERAPY AND AS MAINTENANCE IN CORE-BINDING FACTOR (CBF) ACUTE MYELOID LEUKEMIA (AML): A PHASE IB/IIA STUDY OF THE GERMAN-AUSTRIAN AML STUDY GROUP (AMLSG)

EHA Library, Peter Paschka, 103087

OVEREXPRESSION OF ARGINASE AND PROK-2 MAKES NEUTROPHILS OF MULTIPLE MYELOMA DYSFUNCTIONAL AND IMMUNOSUPPRESSIVE

EHA Library, Alessandra Romano, 103188

PATIENTS WITH HEAVILY PRETREATED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) WHO RESPOND TO ORAL SELINEXOR THERAPY SHOW PROLONGED SURVIVAL: UDPATED PHASE 1 RESULTS

EHA Library, John Kuruvilla, 103169

DEREGULATION OF SNO-RNAS IN THE GENOMICALLY IMPRINTED PRADER-WILLI LOCUS IN ERG-RELATED PEDIATRIC B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Elena Vendramini, 103228

SPIRIT 2: AN NCRI RANDOMISED STUDY COMPARING DASATINIB WITH IMATINIB IN PATIENTS WITH NEWLY-DIAGNOSED CHRONIC MYELOID LEUKAEMIA ? 2 YEAR FOLLOW UP

EHA Library, Stephen O'Brien, 103232

A COMPARISON OF DAUNORUBICIN/ARA-C VERSUS DAUNORUBICIN/CLOFARABINE AS INDUCTION TREATMENT IN OLDER PATIENTS WITH AML AND HIGH RISK MDS: LONG TERM RESULTS OF THE UK NCRI AML16 TRIAL IN 806 PATIENTS.

EHA Library, Nigel Russell, 103226

IMMUNOSUPPRESSION BY MESENCHYMAL STROMAL CELLS DERIVED FROM HUMAN INDUCED PLURIPOTENT STEM CELLS : EVALUATION IN AN AGVHD MODEL

EHA Library, Clémence Roux, 103167

LUSPATERCEPT INCREASES HEMOGLOBIN AND REDUCES TRANSFUSION BURDEN IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM THE PHASE 2 PACE-MDS STUDY

EHA Library, Uwe Platzbecker, 103098

CLINICAL CHARACTERSTICS AND RISK FACTORS OF INTRACRANIAL HAEMORRHAGE IN PATIENTS FOLLOWING ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Xiaohui Zhang, 103100

MANAGEMENT AND OUTCOME OF PRIMARY CNS LYMPHOMA AT FIRST RELAPSE/PROGRESSION: ANALYSIS OF 256 PATIENTS FROM THE FRENCH LOC NETWORK

EHA Library, Sophie Langner-Lemercier, 103054

DISSECTING THE CONTRIBUTION OF UNREGULATED MACROPHAGE IRON RECYCLING AND DIETARY IRON UPTAKE IN GENERATING SYSTEMIC IRON OVERLOAD

EHA Library, Sandro Altamura, 103118

CENTRAL NERVOUS SYSTEM ACUTE LYMPHOBLASTIC LEUKEMIA IS MEDIATED BY VASCULAR ENDOTHELIAL GROWTH FACTOR PROVIDING A NOVEL TARGET FOR DIRECTED THERAPY

EHA Library, Vera Muench, 103116

FUNCTIONAL CHARACTERIZATION OF NOVEL ABCB6 MUTATIONS AND THEIR CLINICAL IMPLICATIONS IN FAMILIAL PSEUDOHYPERKALEMIA.

EHA Library, Immacolata Andolfo, 103150

MIR-153-3P, A NEW BIO-TARGET, IS INVOLVED IN THE PATHOGENESIS OF ACUTE GRAFT-VERSUS-HOST DISEASE THROUGH THE REGULATION OF INDOLEAMINE-2,3-DIOXYGENASE

EHA Library, Xiaosu Zhao, 103139

A COMPARISON OF LIMITED CONSOLIDATION CHEMOTHERAPY THERAPY OR NOT, AND DEMETHYLATION MAINTENANCE OR NOT IN OLDER PATIENTS WITH AML AND HIGH RISK MDS: LONG TERM RESULTS OF THE UK NCRI AML16 TRIAL.

EHA Library, Alan Burnett, 103225

SUBCUTANEOUS VERSUS INTRAVENOUS RITUXIMAB IN COMBINATION WITH CHOP FOR PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA: EFFICACY AND SAFETY RESULTS FROM THE PHASE IIIB MABEASE STUDY

EHA Library, Pieternella (Elly) Lugtenburg, 103114

USEFULNESS OF TARGETED NEXT-GENERATION SEQUENCING IN INHERITED PLATELET DISORDERS WITH UNSPECIFIC PHENOTYPE

EHA Library, Jose Maria Bastida Bermejo, 103080

LONG-TERM OUTCOME OF ALTERNATING NILOTINIB 400 MG TWICE DAILY AND IMATINIB 400 MG ONCE DAILY AS FIRST-LINE TREATMENT OF CHRONIC MYELOID LEUKEMIA: A PHASE 2 STUDY OF THE GIMEMA CML WORKING PARTY

EHA Library, Gabriele Gugliotta, 103206

ANALYSIS OF PROGNOSTIC MARKERS IN 615 PATIENTS WITH THERAPY-RELATED MYELODYSPLASTIC SYNDROMES - ARE CURRENTLY AVAILABLE SCORING SYSTEMS SUITABLE IN THIS PATIENT GROUP?

EHA Library, Andrea Kündgen, 103215

ADDITIONAL PROGNOSTIC VALUE OF CIRCULATING MIR-16 EXPRESSION OVER THE USUAL PROGNOSTIC PARAMETERS IN MULTIPLE MYELOMA PATIENTS

EHA Library, Alberto Rocci, 103196

HEME AND IRON CONTROL OF MACROPHAGE PLASTICITY IS PREVENTED BY THE HEME SCAVENGER HEMOPEXIN AND THE IRON CHELATOR DFO: LESSON FROM SICKLE CELL ANEMIA.

EHA Library, Francesca Vinchi, 103133

ANALYSIS OF TREATMENT AND OUTCOME DATA OF 2904 PATIENTS FROM THE EUTOS POPULATION-BASED REGISTRY

EHA Library, Verena Hoffmann, 103127

COMPOSITE INDEX FOR RISK PREDICTION IN RELAPSED CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Anthony Moorman, 103109

BLEEDING RISK OF SURGERY IN PATIENTS WITH INHERITED PLATELET FUNCTION DISORDERS (IPFD): OUTCOME OF 389 SURGERIES IN 205 PATIENTS

EHA Library, PAOLO GRESELE, 103165

CLINICAL OUTCOME IN OLDER AML PATIENTS NOT FIT FOR INTENSIVE CHEMOTHERAPY: RESULTS OF THE POPULATION-BASED AMLSG-BIO (NCT01252485) REGISTRY STUDY OF THE GERMAN-AUSTRIAN AML STUDY GROUP

EHA Library, Richard Schlenk, 103168

THE PRESENCE OF GENOMIC IMBALANCES IS ASSOCIATED WITH WORSE OUTCOME IN PATIENTS WITH BURKITT LYMPHOMA TREATED WITH DOSE-INTENSIVE CHEMOTHERAPY INCLUDING RITUXIMAB

EHA Library, Jesús MHernández-Rivas, 103082

CLINICAL AND MOLECULAR PREDICTORS OF RESPONSE TO ERYTHROPOIESIS STIMULATING AGENTS (ESA) IN LOWER RISK MDS PATIENTS

EHA Library, Sophie Park, 103058

AN INNOVATIVE HUMANIZED MOUSE MODEL TO INVESTIGATE THE INTERPLAY BETWEEN IMMUNE SYSTEM AND ACUTE MYELOID LEUKEMIA IN ALLOGENEIC HSCT

EHA Library, Giacomo Oliveira, 103214

EXPRESSION LEVELS OF CD38 AND COMPLEMENT INHIBITORY PROTEINS CD55 AND CD59 PREDICT RESPONSE TO DARATUMUMAB IN MULTIPLE MYELOMA

EHA Library, Lotte van der Wagen, 103222

THE B CELL RECEPTOR SIGNALING OUTPUT IN BURKITT?S LYMPHOMA IS GENOTYPE-SPECIFIC AND IMPACTS SENSITIVITY TOWARDS BCR SIGNALING INHIBITORS

EHA Library, Thomas Oellerich, 103128

PROGRESSIVE ANEMIA CAN BE DETECTED MORE THAN 2 YEARS PRIOR TO THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME: RESULTS FROM THE PRIMARY CARE SETTING IN DENMARK

EHA Library, Jakob Werner Hansen, 103126

LEUKEMIA RELAPSES AFTER ALLOGENENIC HSCT DISPLAY A DISTINCTIVE IMMUNE-RELATED SIGNATURE, WITH FUNCTIONALLY RELEVANT ALTERATIONS IN HLA CLASS II ANTIGEN PRESENTATION AND T CELL COSTIMULATION

EHA Library, Cristina TOFFALORI, 103154

DOWN-REGULATED BETA2-GPI IS ASSOCIATED WITH A REDUCED ABILITY TO MITIGATE COMPLEMENT ACTIVATION BY INHIBITING JNK/BID-DEPENDENT PLATELET DESTRUCTION IN THE PATHOGENESIS OF IMMUNE THROMBOCYTOPAENIA

EHA Library, Xiaohui Zhang, 103105

ABERRANT EXPRESSION OF THE STEM CELL MICRORNA-126 INDUCES B CELL MALIGNANCY

EHA Library, Silvia Nucera, 103086

TP-0184 LOWERS HEPCIDIN LEVELS AND IS A POTENTIAL THERAPEUTIC FOR ANEMIA OF CHRONIC DISEASE

EHA Library, Steven Warner, 103178

CONTINUED IMPROVEMENT IN SURVIVAL OF ACUTE MYELOID LEUKEMIA PATIENTS AND AN APPLICATION OF THE LOSS IN EXPECTATION OF LIFE

EHA Library, Åsa Derolf, 103219

EFFICACY AND SAFETY OF FRONTLINE NILOTINIB IN 1089 EUROPEAN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP): ENEST1ST FINAL ANALYSIS

EHA Library, Andreas Hochhaus, 103063

EXOME SEQUENCING POINTS TO DIFFERENCES IN GENETIC INSTABILITY LEVEL IN MGUS COMPARED TO MM

EHA Library, Aneta Mikulasova, 103212

Haematologica Celebration Session: Making blood: the niche in health and disease

EHA Library, David Scadden, 103641

CAR-T Cells

EHA Library, Carl June, 103664

Iron: a global issue in hematology

EHA Library, Clara Camaschella, 103663

Jean Bernard Lifetime Achievement Award: Acceptance Speech

EHA Library, Volker Diehl, 103671

UCART19, AN ALLOGENEIC 'OFF-THE-SHELF' ADOPTIVE T-CELL IMMUNOTHERAPY AGAINST CD19+ B-CELL LEUKEMIAS

EHA Library, Julianne Smith, 103230

RUNX1 MUTATION AND/OR DISRUPTION OF THE C-TERMINAL DOMAIN MAY BE CRITICAL FOR CHRONIC MYELOID LEUKAEMIA (CML) BLAST CRISIS TRANSFORMATION

EHA Library, Lihui Wang, 103066

OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) IN PATIENTS WITH MYELOFIBROSIS (MF) EXPOSED TO JAK1/2 INHIBITORS

EHA Library, Mohamed Shanavas, 103073

UPDATED RESULTS OF A MULTICENTER PHASE I/IB STUDY OF CTLA4 BLOCKADE WITH IPILIMUMAB FOR RELAPSED HEMATOLOGIC MALIGNANCIES AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Matthew Davids, 103200

MICRORNA EXPRESSION BASED OUTCOME PREDICTION IN AML ? CROSS-PLATFORM INTEGRATIVE ANALYSES LEAD THE WAY TO NOVEL INSIGHTS

EHA Library, Velizar Shivarov, 103124

CLINICAL ACTIVITY OF ERY001 (ERYTHROCYTE ENCAPSULATED L-ASPARAGINASE) IN COMBINATION WITH COOPRALL REGIMEN IN PHASE 3 RANDOMIZED TRIAL IN PATIENTS WITH RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Yves Bertrand, 103145

ADHERENCE AND DOSE INTENSITY FOLLOWING ADMINISTRATION OF THE IBRUTINIB 420 MG DOSE IN PATIENTS WITH PREVIOUSLY TREATED CLL

EHA Library, Ulrich Jäger, 103137

PHASE 2 STUDY OF DARATUMUMAB MONOTHERAPY IN PATIENTS WITH ?3 LINES OF PRIOR THERAPY OR DOUBLE REFRACTORY MULTIPLE MYELOMA: 54767414MMY2002 (SIRIUS)

EHA Library, Sagar Lonial, 103136

A HYPOPHOSPHORYLATED AUTOANTIGEN IS THE FIRST MOLECULARLY DEFINED RISK FACTOR AND A DOMINANT ANTIGENIC TARGET / STIMULUS OF THE B-CELL RECEPTOR FROM ABC-TYPE DLBCL

EHA Library, Michael Pfreundschuh, 103187

MUTATION ANALYSIS OF EPIGENETIC MODIFIERS IN CHRONIC PHASE CML USING NEXT GENERATION SEQUENCING

EHA Library, Georgios Nteliopoulos, 103229

ALLOGENIC ADOPTIVE IMMUNOTHERAPY OF ACUTE MYELOID LEUKEMIA (AML) BY TARGETING CD123 WITH CAR T-CELLS

EHA Library, Roman Galetto, 103221

TARGETING EPITHELIAL TO MESENCHYMAL TRANSITION (EMT) THROUGH CXCR4 BLOCKADE IN MULTIPLE MYELOMA

EHA Library, Aldo Roccaro, 103406

EARLY CLINICAL ACTIVITY AND PHARMACODYNAMIC EFFECTS OF DUVELISIB, A PI3K-DELTA,GAMMA INHIBITOR, IN PATIENTS WITH TREATMENT-NA

EHA Library, Susan O'Brien, 103207

EFFECT OF AGE ON EFFICACY AND SAFETY OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA RECEIVING LENALIDOMIDE AND LOW-DOSE DEXAMETHASONE (RD): THE FIRST TRIAL

EHA Library, Cyrille Hulin, 103067

GENOMIC DNA BREAKPOINTS IN MLL AND TRANSLOCATION PARTNER GENES IN A LARGE COHORT OF INFANTS WITH ACUTE LEUKEMIA

EHA Library, Grigory Tsaur, 103220

BCL6 AND EZH2 COOPERATE TO ASSEMBLE NON-CANONICAL PRC1-BCOR COMPLEX TO MEDIATE GERMINAL CENTER FORMATION AND PROMOTE LYMPHOMAGENESIS BY REPRESSING BIVALENT CHROMATIN DOMAINS

EHA Library, Wendy Beguelin, 103199

EXCELLENT LONG-TERM PROGNOSIS OF IMATINIB-TREATED FIP1L1-PDGFRA POSITIVE EOSINOPHILIA-ASSOCIATED MYELOPROLIFERATIVE NEOPLASM IN CHRONIC OR BLAST PHASE

EHA Library, Georgia Metzgeroth, 103077

ALLOGENEIC TRANSPLANTATION FOR MYELOFIBROSIS: HIGH DOSE INTENSITY AND EARLY DISEASE STATE ARE FAVORABLE PROGNOSTIC FACTORS.

EHA Library, Uday Popat, 103097

UTILIZING EXOSOMES AS INNOVATIVE MICRORNA BIOMARKERS AND TARGETED DRUG-DELIVERY VEHICLES IN ACUTE MYELOID LEUKEMIA

EHA Library, Rose McGlauflin, 103115

HUMAN ATRIAL NATRIURETIC PEPTIDE (HANP) THERAPY IN THE EARLY PHASE AFTER ALLOGENEIC STEM CELL TRANSPLANT (ALLO-SCT) PREVENTS DEVELOPMENT OF CHRONIC KIDNEY DISEASE (CKD): RESULTS FROM A PHASE 2 STUDY

EHA Library, Hiroaki Shimizu, 103070

JAM-C: A NEW LEUKEMIC STEM CELL BIOMARKER IN ACUTE MYELOID LEUKEMIA

EHA Library, Maria De Grandis, 103065

RUXOLITINIB (RUX) IN COMBINATION WITH 5-AZACYTIDINE (AZA) AS THERAPY FOR PATIENTS (PTS) WITH MYELOFIBROSIS (MF)

EHA Library, Naval Daver, 103158

THE QUADRUPLET COMBINATION OF CARFILZOMIB, CYCLOPHOSPHAMIDE, LENALIDOMIDE, AND DEXAMETHASONE IS SAFE AND WELL TOLERATED AS INDUCTION THERAPY FOR NEWLY DIAGNOSED, TRANSPLANT ELIGIBLE, MYELOMA PATIENTS.

EHA Library, Charlotte Pawlyn, 103110

HIGH THROUGHPUT SEQUENCING AS A MEASURE OF EARLY RESPONSE TO THERAPY IN CHILDHOOD ALL

EHA Library, Ilan Kirsch, 103135

A THERAPEUTIC NKT CELL ADJUVANT-BASED VACCINE INDUCES AN EFFECTIVE ANTITUMORAL IMMUNE RESPONSE IN B-CELL LYMPHOMA

EHA Library, Laura Escribà, 103143

CORRECTION OF MUTATIONS OF THE EPIGENETIC MODIFIER ASXL1 IN MYELOID LEUKEMIA CELLS BY CRISPR/CAS9 GENOME EDITING

EHA Library, Simona Valletta, 103146

IDENTIFICATION OF DIFFERENTIALLY METHYLATED DISTANT ENHANCERS RELATED TO ABERRANT EXPRESSION OF SOX11 IN MANTLE CELL LYMPHOMA

EHA Library, Renée Beekman, 103148

EFFECT OF CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE VS LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA BY LINE OF THERAPY: INTERIM RESULTS FROM THE PHASE 3 ASPIRE STUDY

EHA Library, Meletios Dimopoulos, 103134

GENERATION OF EBV-SPECIFIC AND EBV-SPECIFIC, TCR-REPROGRAMMED HUMAN CD8+ CYTOTOXIC T LYMPHOCYTES WITH STEM CELL MEMORY AND CENTRAL MEMORY PROPERTIES BY MODULATING GLYCOLYTIC T CELL METABOLISM

EHA Library, Udo Hartwig, 103117

MYC-MAX HETERODYMER POSITIVELY REGULATES BCR AND BCR/ABL EXPRESSION

EHA Library, Vera Magistroni, 103142

NPM-ALK MIMICS THYMIC PRE-T CELL RECEPTOR (TCR) EXPANSION BUT REQUIRES TRANSIENT TCR EXPRESSION FOR THYMIC EGRESS AND PERIPHERAL ANAPLASTIC LARGE CELL LYMPHOMA DEVELOPMENT

EHA Library, Amélie Trinquand, 103155

RUXOLITINIB VERSUS BEST AVAILABLE THERAPY IN PATIENTS WITH POLYCYTHEMIA VERA: 80-WEEK FOLLOW-UP FROM THE RESPONSE TRIAL

EHA Library, Jean-Jacques Kiladjian, 103108

TGR-1202, A NOVEL ONCE DAILY PI3K-DELTA INHIBITOR, DEMONSTRATES CLINICAL ACTIVITY WITH A FAVORABLE SAFETY PROFILE, LACKING HEPATOTOXICITY, IN PATIENTS WITH CLL AND B-CELL LYMPHOMA

EHA Library, Howard A.Burris, 103192

Mycosis Fungoides: Diagnostic Considerations

EHA Library, Patty Jansen, 103613

THE PREDICTIVE STRENGTH OF NEXT GENERATION SEQUENCING MINIMAL RESIDUAL DISEASE DETECTION FOR RELAPSE COMPARED WITH CURRENT METHODS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Michaela Kotrová, 103071

LEUKAEMIA-ASSOCIATED SOMATIC MUTATIONS DRIVE DISTINCT PATTERNS OF AGE-RELATED CLONAL HAEMOPOIESIS

EHA Library, Thomas McKerrell, 103060

KIR2DS4 AND ITS VARIANT KIR1D ARE ASSOCIATED WITH AGVHD, CMV AND OS AFTER SIBING RELATED HLA MATCHED TRANSPLANTATION FOR PATIENTS WHOSE DONORS BELONG TO KIR GENE HAPLOTYPE A

EHA Library, Xiaojin Wu, 103052

SECOND GENERATION TYROSINE KINASE INHIBITORS SUPPRESS THE CIP2A/C-MYC/E2F1 PATHWAY

EHA Library, Richard Clark, 103121

VENETOCLAX (ABT-199 / GDC-0199) COMBINED WITH RITUXIMAB INDUCES DEEP RESPONSES IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Andrew W Roberts, 103125

DROPLET DIGITAL PCR FOR DNMT3A AND IDH1/2 MUTATIONS TO IMPROVE EARLY DETECTION OF ACUTE MYELOID LEUKEMIA RELAPSE AFTER ALLOGENEIC HSCT

EHA Library, Chiara Brambati, 103151

RISK FACTORS FOR THROMBOHEMORRHAGIC AND TRANSFORMATION EVENTS IN 3649 HIGH-RISK PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA: RESULTS FROM THE PROSPECTIVE LONG-TERM OBSERVATIONAL EXELS STUDY

EHA Library, Gunnar Birgegard, 103157

TYROSINE KINASE FUSION GENES IN PEDIATRIC BCR-ABL1-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Judith Boer, 103107

RESULTS FROM TWO PHASE 3 STUDIES OF POST-TRANSPLANT BORTEZOMIB (BTZ) CONSOLIDATION VS OBSERVATION (OBS) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)

EHA Library, Hermann Einsele, 103092

DNMT3A MUTATIONS IN ACUTE MYELOID LEUKEMIA (AML): MONITORING OF MINIMAL RESIDUAL DISEASE (MRD). A STUDY OF THE AML STUDY GROUP (AMLSG).

EHA Library, Verena I Gaidzik, 103190

OUTCOMES OF GENE THERAPY FOR ?-THALASSEMIA MAJOR AND SEVERE SICKLE DISEASE VIA TRANSPLANTATION OF AUTOLOGOUS HEMATOPOIETIC STEM CELLS TRANSDUCED EX VIVO WITH A LENTIVIRAL BETA GLOBIN VECTOR

EHA Library, Marina Cavazzana-Calvo, 103175

THE LANDSCAPE OF SOMATIC ALTERATIONS IN ADULT T-CELL LEUKEMIA/LYMPHOMA

EHA Library, Keisuke Kataoka, 103057

Novel Biological Insights In Primary Cutaneous T-cell Lymphomas Other Than Mycosis Fungoides

EHA Library, Leticia Quintanilla de Fend, 103612

Therapeutic principles in primary cutaneous T-cell lymphomas

EHA Library, Emmanuella Guenova, 103614